Experts discuss physiological mechanisms behind the opioid epidemic and present their research on the effects of opioids on sleep and respiratory depression in preclinical mouse models.

The opioid crisis can be traced back to the 1990s. Amid rising demand for pain relief, pharmaceutical companies assured doctors that their drugs carried little risk of addiction, and doctors began prescribing them at a higher rate. Since then, prescription, production and misuse of opioids have risen dramatically. In 2017 alone, an estimated 1.7 million Americans suffered from substance abuse disorders involving prescription or illegal opioids, with some 47,000 deaths due to overdose. Clearly, more research is required to better understand and prevent opioid misuse.

In this webinar sponsored by Data Sciences International, Dr. Ralph Lydic and Dr. Tally Largent-Milnes discuss the role of respiratory and neuroscience research in addressing the opioid epidemic. Dr. Ralph Lydic, professor of neuroscience and co-director of anesthesiology research at the University of Tennessee, presents data demonstrating the systemic and neurological effects of opioids on breathing and sleep in rodent models. Following, Dr. Tally Largent-Milnes, assistant professor of pharmacology at the University of Arizona, presents research investigating how cannabinoid receptors modulate opioid-induced respiratory depression in rodent models.

Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.


To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.


Robert H. Cole Endowed Professor of Neuroscience, Co-Director of Anesthesiology Research
University of Tennessee Graduate School of Medicine

Ralph Lydic, Ph.D. serves as Professor of Anesthesiology and Psychology at University of Tennessee, and Professor Emeritus at University of Michigan. He holds a Joint Faculty appointment at Oak Ridge National Laboratory. Dr. Lydic is a neuroscientist and his research aims to achieve a better understanding of how the brain regulates sleep states and anesthesia, and elucidating the mechanisms by which sleep, opioids, and volatile anesthetics modulate pain and depress breathing and arousal.

Assistant Professor of Pharmacology
University of Arizona

Dr. Largent-Milnes received her Ph.D. in Medical Pharmacology from the University of Arizona in 2010 and was an F32 funded postdoctoral fellow at Oregon Health and Science University in Physiology and Pharmacology. She returned to the University of Arizona to start her independent research program (2014). Her long-term research interests focus on how behavior is influenced by both disease pathology and pharmacotherapy. Overarching themes of the Largent-Milnes lab are to better understand the underlying neurophysiology and pathophysiology of chronic pain and drug misuse/abuse to develop novel therapeutics to improve patient quality of life. She has published 50 peer-reviewed manuscripts and is currently funded as a PI by NINDS and the Arizona Biomedical Research Commission and serves as a co-investigator on two NIDA grants.

Production Partner

Data Sciences International

Data Sciences International (DSI) is the leader in preclinical physiological monitoring offering telemetry, instrumentation, software and services to help advance science. Industries served include: Pharmaceuticals, Academia, Contract Research Organizations, Biological and Chemical Defense, Medical Devices, Government, and Biotechnology.

Harvard Bioscience, Inc.

Harvard Bioscience is a global leader in the manufacturing and distribution of solutions to advance life science research. For over 110 years, we have served the changing needs of life scientists in over 100 countries. Our expanding portfolio of brands include instruments for organ and animal research, cell analysis, molecular biology, fluidics, and laboratory consumables.

Additional Content From Data Sciences International

Additional Content From Harvard Bioscience, Inc.

Related Content